National Cancer Center;Chugai Seiyaku Kabushiki Kaisha
发明人:
申请号：
EP11786743.2
公开号：
EP2578233B1
申请日:
2011.05.27
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
We achieved the present invention on the basis of the finding that an excellent therapeutic effect against pancreatic cancer can be obtained by administering an IL-6 inhibitor and an antimetabolite to pancreatic cancer patients. We also found that metastatic lesions from human pancreatic cancer can be reduced and ascites can be eliminated.
